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Abstract
It is becoming increasingly apparent that Staphylococcus aureus are able to survive engulfment by macrophages, and that the
intracellular environment of these host cells, which is essential to innate host defenses against invading microorganisms, may
in fact provide a refuge for staphylococcal survival and dissemination. Based on this, we postulated that S. aureusmight induce
cytoprotective mechanisms by changing gene expression profiles inside macrophages similar to obligate intracellular
pathogens, such as Mycobacterium tuberculosis. To validate our hypothesis we first ascertained whether S. aureus infection
could affect programmed cell death in human (hMDMs) and mouse (RAW 264.7) macrophages and, specifically, protect these
cells against apoptosis. Our findings indicate that S. aureus-infected macrophages are more resistant to staurosporine-induced
cell death than control cells, an effect partly mediated via the inhibition of cytochrome c release from mitochondria.
Furthermore, transcriptome analysis of human monocyte-derived macrophages during S. aureus infection revealed a
significant increase in the expression of antiapoptotic genes. This was confirmed by quantitative RT-PCR analysis of selected
genes involved in mitochondria-dependent cell death, clearly showing overexpression of BCL2 and MCL1. Cumulatively, the
results of our experiments argue that S. aureus is able to induce a cytoprotective effect in macrophages derived from different
mammal species, which can prevent host cell elimination, and thus allow intracellular bacterial survival. Ultimately, it is our
contention that this process may contribute to the systemic dissemination of S. aureus infection.
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Introduction
Staphylococcus aureus is a major human pathogen causing
significant morbidity and mortality due to both community- and
hospital-acquired infections. This pathogen causes a variety of
diseases, including impetigo, cellulitis, food poisoning, toxic shock
syndrome, necrotizing pneumonia, and endocarditis [1,2]. Local-
ised S. aureus infections are often followed by bacterial invasion of
the vascular system, leading to bacteraemia and sepsis. A large
number of virulence factors are known to contribute to
pathogenesis, e.g. surface proteins that support colonization of
host tissues, invasins (hyaluronidase) and proteases that promote
bacterial spreading, surface factors (protein A) that inhibit
phagocytic engulfment or toxins (hemolysins, leukotoxin, exotox-
ins) that damage host-cell membranes [1,3]. The treatment of S.
aureus infections is increasingly problematic due to the high
prevalence of multi-antibiotic resistant strains, such as methicillin-
resistant S. aureus (MRSA) [4], and the emergence of glycopeptide-
insensitive (GISA) [5] and vancomycin-resistant S. aureus strains
(VRSA) [6].
For many years S. aureus was classified as a typical extracellular
pathogen. However, recent experiments assessing invasion and the
intracellular survival of S. aureus in endothelial and epithelial cells,
and osteoblasts [7–9], suggests that such events may contribute to
the persistence of S. aureus during infections such as endocarditis,
bovine mastitis and osteomyelitis [10]. Moreover, it has long been
known that professional phagocytes may serve as intracellular
reservoirs of S. aureus [11]. In keeping with this idea, recent in vitro
studies have confirmed high level resistance by S. aureus to
neutrophil [12] and macrophage [13] mediated killing.
Professional phagocytes play a key role in host defence by
recognizing, engulfing, and killing microorganisms; yet only a
small group of pathogens can persist inside these cells, evading
host defences. In mammals various intracellular pathogens have
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evolved strategies, including the modulation of programmed cell
death (PCD), which favours their survival. One such strategy,
utilized by some bacteria, viruses and parasites, involves the
induction of apoptosis in immune effector cells like neutrophils and
macrophages [14,15]. This kind of strategy seems to be employed
by S. aureus infections, not only in epithelial and endothelial cells,
but also in neutrophils and monocytes [8,9,16–18]. One may
argue, however, that apoptosis of infected cells constitutes part of
host defense, limiting the dissemination of intracellular microor-
ganisms by prompting the effective clearance of infected cells by
resident and recruited phagocytes [19]. The converse of this
strategy is the repression of programmed cell death in invaded host
cells, allowing the pathogen to replicate and/or silently persist,
whilst remaining invisible to the immune system [20,21]. Well-
known pathogens which employ this strategy include Legionella
pneumophila, Chlamydiae spp., Rickettsia rickettsii, and Neisseria gonor-
rhoeae [22]. Within this category two divergent approaches are
employed by pathogens to protect their intracellular niche.
Obligate intracellular bacteria either activate cellular processes,
which render the infected mammalian cells resistant to apoptotic
stimuli, or directly interfere with the apoptotic apparatus [23].
Apoptosis is a form of programmed cell death that is highly
regulated and consists of diverse upstream pathways for the
transmission of extracellular death signals into intracellular events.
One apoptosis pathway, referred to as extrinsic, involves apoptosis
mediated by death receptors, such as CD95 (Fas) and tumor
necrosis factor-a (TNF-a) receptors [24]. On the other hand, in the
intrinsic apoptosis pathway, various proapoptotic signals converge
at the mitochondrial level, provoking the release of cytochrome c
from mitochondria into the cytosol [25]. In the cytosol, cytochrome
c binds Apaf-1 and activates caspase-9, which in turn activates
caspase-3. Activation of the executioner caspases leads to cleavage
of a variety of target proteins with structural or regulatory functions,
including poly(ADP-ribose) polymerase (PARP), protein kinase C,
nuclear lamins, and others causing silent cell destruction from
within. The intrinsic pathway is regulated by several proteins
associated with the mitochondrial outer membrane. Whereas
proteins of the Bcl-2 family (e.g., Bcl-2, Bcl-xL or Mcl-1) exert
antiapoptotic activity, the Bax and Bak proteins stimulate cell death
[26]. These antiapoptotic molecules prevent translocation of
cytochrome c from the mitochondria, while dimerization of
proapototic proteins results in cytochrome c release. Moreover,
overexpression of antiapoptotic factors, such as Bcl-2 and Bfl-1, has
been demonstrated to abrogate the function of proapoptotic
proteins, and elicit a protective effect on host cells [27]. In contrast,
overexpression of proapoptotic members of this family, including
Bax, has been shown to induce apoptosis [28]. Therefore, the
expression levels of either pro- or antiapoptotic factors plays an
important role in determining the life-or-death decision of host cells.
Previous studies have shown that macrophages respond to
intracellular pathogens, e.g. Mycobacterium tuberculosis infection, by
transient activation of host cell signal transduction pathways, which
leads to alterations in gene expression, and the induction of
cytoprotective mechanisms [29,30].
A recent study by our group has shown that S. aureus can persist
inside macrophages for several days without affecting the viability
of these cells [13]. To analyze the strategies adopted by S. aureus for
survival within human monocyte-derived macrophages, we
investigated whether macrophages infection by S. aureus in vitro
can affect (enhance or prevent) staurosporine-triggered apoptosis
in host cells. We found that S. aureus is capable of protecting
macrophages from staurosporine-induced apoptosis by preventing
cytochrome c release and the associated subsequent activation of
caspase-3. We also defined gene expression profiles of human
monocyte-derived macrophages after S. aureus infection. Micro-
array analysis revealed a significant upregulation of antiapoptotic
genes, especially those involved in mitochondrial pathways, and, in
stark contrast, a decrease in expression of proapoptotic genes.
Materials and Methods
Cell culture and phagocytosis assay
Human monocyte-derived macrophages (hMDMs) were sepa-
rated from fractions of peripheral blood mononuclear cells
(PBMCs) obtained from the blood of healthy donors using a
lymphocyte separation medium (LSM; PAA) density gradient [13].
Blood was obtained from the Red Cross (RC), Krakow, Poland.
RC de-identified blood materials as appropriate for human
subjects confidentiality assurance. Thus, the current manuscript
adheres to appropriate exclusions from human subjects approval.
PBMCs were seeded at concentrations of 26107 and 36106 cells/
well into 6-well and 24-well plates, respectively, and cultured in
RPMI1640 medium (PAA) supplemented with 10% heat-inacti-
vated autologous human plasma, 2 mM L-glutamine, and 50 mg/
mL gentamicin (Sigma) in a humidified atmosphere of 5% CO2.
After 24 h, non-adherent cells were removed and adherent
monocytes were differentiated to macrophages for 7–10 days,
with fresh medium changes every second day. The hMDMs
phenotype was evaluated by immunofluorescent staining for CD14
(DakoCytomation), CD16 (DakoCytomation), CD11b (Becton
Dickinson), and CD209 (Becton Dickinson) of detached cells and
subsequent flow cytometry analysis. The routine procedure used in
our laboratory yields at least 90% cells positive for the first three
antigens with less than 1% cells staining with anti-CD209
antibodies. The murine macrophage cell line RAW 264.7 was
maintained in DMEM (PAA) supplemented with 5% fetal bovine
serum (FBS; PAA). Macrophage infection was performed using the
Newman strain of S. aureus (kindly provided by T. Foster),
Escherichia coli or Bacillus subtilis (both from laboratory stocks). To
exclude the possibility that cytoprotective effects were the result of
unspecific cell activation, experiments using latex beads (1.1 mm;
Sigma) and 20 ng/mL PMA (Sigma) to stimulate macrophages
were conducted. Bacterial strains were stored and cultivated as
described previously [13]. Heat treatment (80uC for one hour) was
used to kill bacteria. The viability of live and heat-treated bacteria
was routinely verified by plating dilutions on TSB agar and
counting colonies to determine CFU/mL. Phagocytosis assays
were carried out for 2 hours at 37uC at a multiplicity of infection
(MOI) of 1:50 (hMDMs) or 1:5 (RAW 264.7). After that time cells
were rinsed 4 times with ice-cold phosphate-buffered saline (PBS;
PAA). Any remaining non-phagocytosed bacteria were killed by
culturing in medium containing 50 mg/mL gentamicin for 24 h.
The medium was then replaced with fresh media without
antibiotics, and cultures were maintained for the desired time.
Viability assays
After S. aureus phagocytosis and/or treatment with inducers of
apoptosis, macrophage viability was examined by lactate dehy-
drogenase (LDH) release or 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyl tetrazolium bromide (MTT) reduction assays. The LDH
release assay was performed using a CytoTox96 Non-Radioactive
Lactate Dehydrogenase Cytotoxicity Assay kit (Promega). Infected
and control hMDMs in a 24-well tissue culture plate (36105 cells
per well) were treated with 1 mM staurosporine (STS; Sigma)
added 24 h post-infection as a stimulator of apoptosis. Samples
were then incubated for 24 h, followed by the removal of 200 mL
of culture medium, and transferred to a 96-well, flat-bottom plate.
The LDH substrate was added to each well and incubated for
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30 min at 37uC in the dark. LDH activity in the medium,
corresponding to macrophage necrosis, was measured as an
absorbance at 490 nm using an ELISA plate reader (SpectraMax
250; Molecular Devices). Cytotoxicity was calculated with the
formula: % cytotoxicity = (experimental value - low control)6100/
(high control – low control), where the low control is assay medium
and the high control is assay medium supplemented with 2%
Triton X-100 plus cells to define the maximum LDH release.
Spontaneous release was always found to be below 10% of the
maximum release. The mitochondrial activity of control and S.
aureus-infected hMDMs treated with apoptotic stimuli was
determined by the ability of mitochondrial succinate dehydroge-
nase to convert MTT to the blue compound formazan. Briefly,
24 h after the phagocytosis of S. aureus, hMDMs were stimulated
with STS for 24 hours. Subsequently, 0.5 mL of the MTT reagent
(Sigma) dissolved in serum free RPMI1640 (0.5 mg/mL) was
added to the cells, followed by incubation at 37uC for 2 hours. Any
formed formazan crystals were dissolved by adding acidified
isopropanol solution, and the absorbance of the solution was
spectrophotometrically measured at a wavelength of 570 nm. Any
increase or decrease in mitochondrial activity results in a
concomitant change in the amount of formazan formed, indicating
the degree of cytotoxicity caused by bacterial infection and/or
proapoptotic treatment. All assays were performed in triplicate.
Fluorescence microscopy
An early feature of apoptosis, the externalization of anionic
phospholipid phosphatydylserine (PS), was assessed by annexin V
binding to surface exposed PS using an annexin V-FITC kit
(Bender Med Systems). Briefly, macrophages were incubated for
up to 6 h after phagocytosis of S. aureus. At the time points
indicated, 26106 cells were labeled with FITC-conjugated
annexin V in 2% RPMI for 15 min at RT in darkness, and
processed according to the manufacturer’s protocol.
49-6-Diamidino-2-phenylindole (DAPI; Sigma), which forms a
fluorescent complex with natural double-stranded DNA, was used
to stain the nuclei of hMDMs after S. aureus phagocytosis. At the
time points indicated cells were washed with PBS and then
incubated for 10 min on ice with PBS containing 0.1% Triton X-
100. Permeabilized cells were then treated with 4% PBS buffered
paraformaldehyde solution containing 10 mg/mL DAPI. The
morphology of cell nuclei was examined at an excitation
wavelength of 350 nm. Nuclei were considered to have a normal
phenotype when glowing brightly and homogenously. Apoptotic
nuclei were identified by condensed chromatin.
Propidium iodide (PI; Molecular Probes) staining was per-
formed to assess the integrity of macrophage plasma membranes
after phagocytosis of bacteria and/or treatment with inducers of
apoptosis.
Analysis of phagocytosed, FITC-labeled S. aureus by macro-
phages was performed as follows. Bacterial samples, prepared as
described in the cell culture section, were washed and resuspended
in PBS containing FITC at a final concentration 100 mg/mL,
followed by incubation for 30 min at 37uC. After incubation the
bacteria were extensively washed and phagocytosis assays were
performed as described previously. For those macrophages that
engulfed S. aureus – FITC was observed using a Nikon Eclipse Ti
microscope.
Analysis of caspase-3 activity
The activity of caspase-3, a main executioner protease involved
in the apoptotic process, was determined by release of 7-amino-4-
trifluoromethyl-coumarin (AFC) from a DEVD-AFC peptide
substrate (Sigma). Cells (26106), both control and samples exposed
to S. aureus, with or without apoptotic stimuli were collected by
centrifugation (2006g, 5 min, 4uC), washed with ice-cold PBS and
resuspended in 100 mL of lysis buffer (50 mM Tris, pH 7.5,
150 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS).
Samples were then incubated on ice for 20 min to lyse cells, with
lysates recovered by centrifugation at 16,0006g for 10 min. The
protein content of supernatants was measured using the BCA
method. Caspase activity was determined by transferring aliquots
of supernatant into buffer (40 mM Pipes, 20% sucrose, 200 mM
NaCl, 0.2% CHAPS, 2 mM EDTA) containing DEVD-AFC and
recording the increased fluorescence (lex = 350 nm, lem =
460 nm) of any released AFC using a Spectra Max Gemini EM
(Molecular Devices). Additionally, the cleavage of polyadenosine-
diphosphate-ribose polymerase (PARP) from its native 116 kDa to
its processed 85 kDa form by caspase-3 was determined from
cellular pellets via Western blot.
DNA fragmentation
Briefly, 26106 S. aureus and/or apoptotic, stimuli-treated or
untreated macrophages were washed with cold PBS, harvested
and collected by centrifugation (2006g, 5 min). Cells were then
resuspended in 350 mL of lysis buffer (10 mM Tris pH 7.8, 5 mM
EDTA, 0.5% SDS) and incubated at 65uC for 60 min. Lysates
were then treated with RNaseA (30 mg/mL, 37uC, 1 h; Fermen-
tas) and proteinase K (30 mg/mL, 50uC, 1 h; Fermentas) and
extracted twice with an equal volume of phenol-chloroform. DNA
was then precipitated at 220uC with 0.3 M sodium acetate 295%
ethanol for 24 h. Precipitated DNA was harvested by centrifuga-
tion (13,0006g, 10 min, 4uC), washed with ice-cold 75% ethanol
and dried. DNA was then dissolved in 30 mL of Tris-EDTA buffer
and subjected to electrophoresis on a 2% agarose gel containing
ethidium bromide (1 mg/mL) at 5 V/cm for 90 min. The
analyzed DNA samples were compared with standard size
fragments using a 1 kb DNA marker (Promega). DNA fragmen-
tation and degradation was visualized by UV light and
photographed.
Flow cytometric analysis
Flow cytometric analysis was performed to assess changes in
mitochondrial membrane potential (Dym) and to estimate the
amount of mitochondria in S. aureus-treated hMDMs. To evaluate
changes in ym, infected and control hMDMs were stained for
15 min at 37uC with 200 nM MitoTracker Red CMXRos
(Invitrogen), a potential-sensitive fluorescent dye. After incubation
cells were harvested and analyzed by a FACScan flow cytometer
(Becton Dickinson) using the CellQuest software.
Protein isolation and Immunoblotting
Whole cellular extracts from control and stimulated cells were
prepared from cells detached using a rubber policeman, and
harvested from culture medium into Eppendorf tubes. Cells were
washed twice with PBS (2506g, 5 min), suspended in 100 mL of
RIPA-lysis buffer (0.25% Na-deoxycholate, 0.5% Nonidet P-40,
0.05% SDS, protease inhibitor cocktail, 2.5 mM EDTA in PBS)
and stored at 220uC.
For cytochrome c release and mitochondrial protein analysis,
cells were fractionated into mitochondrial and cytoplasmic
fractions. Briefly, 16107 hMDMs were scraped and collected by
centrifugation (2006g, 5 min). Pellets were then washed twice with
cold PBS, resuspended in buffer A (20 mM HEPES-KOH pH 7.4,
250 mM sucrose, 10 mM KCl, 1.5 mM Na-EGTA, 2 mM DTT,
protease inhibitor cocktail) and incubated on ice for 20 min. Next,
cells were disrupted by 30 circles of shearing through an insulin
needle, followed by centrifugation (8006g, 10 min, 4uC). Mito-
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chondria in the supernatant were pelleted by centrifugation
(22,0006g, 15 min, 4uC). The resulting supernatant, representing
the soluble cytoplasmic fraction, was frozen at 270uC, while the
mitochondrial pellets were lysed with buffer B (50 mM HEPES
pH 7.4, 1% Nonidet P-40, 10% glycerol, 1 mM EDTA, 2 mM
DTT, protease inhibitor cocktail) during 20-min incubation on ice.
Debris were removed by centrifugation (22,0006g, 15 min, 4uC)
and the absence of cytoplasmic contamination was confirmed by
the negligibly low level of the lactate dehydrogenase activity in this
fraction. Supernatants containing mitochondrial proteins were
stored at 270uC.
Equal amounts of protein from either whole cell extracts or
subcellular fractions were separated using SDS-PAGE (8%, 12%
or 16% gels depending on the molecular mass of the proteins of
interest) and electrotransferred onto nitrocellulose membranes
(Immobilon-PSQ; Millipore or nitrocellulose BioRad) in buffer
composed of 25 mM Tris, 0.2 M glycine, 20% methanol (30 V,
overnight). Membranes were stained with Ponceau S to analyze
the efficiency of transfer and the equal loading of samples. Non-
specific binding sites were blocked with 3% BSA in TTBS buffer
(20 mM Tris, pH 7.5, 0.5 M NaCl, 0.05% Tween 20) for 1 h,
followed by 1–2 hours incubation with the relevant primary
antibody: 2,000-fold diluted anti-PARP (Biomol), 1,000-fold
diluted anti-caspase-3 (Santa Cruz Biotechnology), 2,000-fold
diluted anti-cytochrome c (BD Biosciences), 3,000-fold diluted
anti-b-actin (Sigma) 2,000-fold diluted anti-COX IV (Molecular
Probes), 1,000-fold diluted anti-cathepsin D (Calbiochem). Mem-
branes were washed extensively in TTBS buffer and incubated
with secondary horseradish peroxidase (HRP)-conjugated anti-
bodies, donkey anti-rabbit IgG (Promega, 20,000-fold diluted or
Amersham, 10,000-fold diluted) or sheep anti-mouse IgG (Sigma,
20,000-fold diluted), for 1 h in TTBS buffer containing 1% BSA.
Membranes were washed (4615 min) in TTBS buffer and blots
were developed via ECL detection (Western Blotting Detection
Reagents; Amersham Biosciences).
Microarray analysis
Phagocytosis assays were performed using 26106 hMDMs as
described previously. Control and S. aureus-exposed cells (8, 24 and
48 h post-infection) were washed twice with PBS and RNA was
isolated using a RNeasy Mini Kit (Qiagen) according to the
manufacturer’s instructions. Microarray analysis was performed
using HU133+2 human Affymetrix GeneChips as described
earlier [31] but with modifications. Experiments were performed
using hMDMs from 5 donors at each time point, using a separate
GeneChip for each donor. Affymetrix GeneChip Operating
Software (GCOS v1.4, http://www.affymetrix.com) was used to
perform the preliminary analysis of the GeneChips. All GCOS
*.cel files were scaled to a trimmed mean of 500 to produce the
*.chp files. A pivot table with all samples was created and included
calls, call p-value and signal intensity for each gene. The pivot
table was then imported into GeneSpring GX 7.3 (http://www.
chem.agilent.com). Hierarchical clustering (condition tree) using a
Pearson correlation similarity measure with average linkage was
used to produce a dendrogram that indicated biological replicates
were grouping together. A separate analysis was prepared from the
*.cel files by directly importing the files into Partek Genomics Suite
software (Partek Inc. Saint Louis, Mo.) and running the quantile
normalization to produce a principal component analysis (PCA)
plot. An ANOVA was run from this normalization to produce p-
values corrected for multiple comparisons using the false discovery
rate (FDR). Significance Analysis of Microarrays (SAM) was also
performed and these data were combined into a single custom
Excel worksheet consisting of all statistical and quality filters to
produce the final gene list. We initially defined genes as
differentially expressed when changes in transcript levels were
statistically significant by ANOVA and were at least 2-fold
increased or decreased compared with unstimulated cells, and
transcripts has to pass all quality filters. Complete microarray data
are posted on the Gene Expression Omnibus (GEO, http://www.
ncbi.nlm.nih.gov/geo/, accession number GSE13670).
RNA extraction and Quantitative Real-Time PCR
Total RNA was extracted from cultured hMDMs using a
RNeasy Mini Kit (Qiagen) according to the manufacturer’s
instructions. RNA samples were DNAse treated (Roche) and used
for cDNA synthesis reactions in a total volume of 20 mL
containing 0.5 mg of each RNA sample, 0.5 mg oligo (dT)18
primer, 20 U of RiboLock Ribonuclease Inhibitor, 1 mM dNTP
mix and 40 U of M-MuLV Reverse Transcriptase (RevertAidTM
First Strand cDNA Synthesis Kit; Fermentas). Quantitative PCR
reactions were performed using a qPCR SYBR Green Kit
(Finzymes) and a Rotor-Gene RG-3000 real-time thermocycler
(Corbett Research), with a final reaction volume of 20 mL. The
reaction mixes contained 1 mL of cDNA sample, 0.2 mM of each
primer and a relevant fluorogenic probe. Forward and reverse
primer sequences specific for BCL2, BAX, MCL1 and the house
keeping EF2 gene are listed in Table 1. After 5 min of initial
denaturation at 95uC, reactions were carried out at the following
conditions: denaturation, 95uC for 20 sec; annealing, 62uC for
20 sec; extension, 72uC for 30 sec; followed by a final elongation
step of 72uC for 20 min. Triplicate samples were analyzed for each
reaction and the mean values calculated. Data analysis was
conducted using the ‘‘delta-delta Ct’’ quantification method [32].
qPCR reaction products were resolved on non-denaturing 1.5%
agarose gels and visualized by staining with ethidium bromide.
Statistics
Results were analyzed for statistical significance using the
Student’s t-test. Differences were considered significant when
p,0.05.
Results
S. aureus induces an incomplete activation of apoptosis
during intracellular survival in hMDMs
Macrophages are fairly resistant to apoptosis, as interaction with
some bacterial pathogens and/or their toxins induces only limited
apoptosis in these cells [21,33]. In keeping with this finding, we
have recently shown that the phagocytosis of S. aureus by hMDMs
leads to a prolonged intracellular survival of this pathogen in
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phagocytes without affecting the viability of host cells [13]; despite
a transient increase in caspase-3 activity in the infected cells. To
explore this observation further hMDMs were infected with S.
aureus strain Newman, and, at different time points, a variety of
tests to detect apoptosis were conducted. Cells treated identically,
but without S. aureus, were also analyzed in all experiments as a
control (mock-infected cells). In most analyses 1 mM staurosporine
was used as a positive control for apoptotic induction. Macro-
phages infected with S. aureus and control cells were stained with
FITC-conjugated annexin V to detect an early event in apoptosis,
the exposure of phosphatidylserine on the cell surface. In contrast
to mock-infections, in which the appearance of apoptotic cells was
sporadic (2.160.65%), the phagocytosis of S. aureus increased the
number of annexin-positive/PI-negative cells by up to 20% of total
cell counts (15.563.25%) (Fig. 1A). S. aureus uptake was associated
with the activation of caspase-3 only in a subset of cultures. Out of
25 hMDMs cultures from different donors, the robust activity of
caspase-3 (100–250 RFU/min) was observed only in 3 cases
(12%), whilst in 9 cases (36%) macrophages responded with a
moderate increase in activity (10–80 RFU/min). In the majority of
infected hMDMs cultures, no increase in caspase-3 activity was
observed 24 h post-phagocytosis, when compare to control cells
(Fig. 1B). Moreover, infected in vitro individual hMDMs cultures
exhibited very similar bacterial load (CFU in cell lysates) in
consecutive days post-phagocytosis. This strongly suggests that
diverse level of caspase-3 activity is donor-dependent. Using
hMDMs from selected donors we determined changes in caspase-3
activity during prolonged S. aureus infection over the course of
168 h. In all cases of significant, S. aureus-triggered caspase-3
activation, the maximal activity occurred at 24 h post-phagocy-
tosis, and then decreased to control levels (Fig. 1C). In these
cultures caspase-3 activity was correlated with the accumulation of
a signature PARP fragment (p85), resulting from PARP cleavage
by caspase-3 (data not shown). Nevertheless, despite this clear
apoptotic pathway activation feature (very high activation of
caspase-3), no hallmarks of late apoptotic changes, such as DNA
fragmentation, were observed in infected hMDMs (Fig. 1D). The
DNA integrity of infected cells was also confirmed by negative
results from the TUNEL assay, which visualizes fragmented
chromosomal DNA from apoptotic cells via the incorporation of
fluorescein-12-dUTP at its 3-ends (data not shown). Furthermore,
morphological analysis of DAPI-stained cells only occasionally
revealed slightly condensated nuclei 460.5% (Fig. 1E, arrow) at
24 h post-phagocytosis. In all cases, the presence of significant
numbers of apoptotic nuclei was undetectable throughout the
infection. Taken together our results indicate that S. aureus is able
to induce the initial steps of apoptosis, including phosphatidylser-
ine exposure, decrease of mitochondrial potential, release of
cytochrome c and caspase-3 activation, in donor-dependent
manner; yet this does not lead to finalization of the apoptotic
process (no oligonucleosomal DNA fragmentation or secondary
necrosis features). With respect to the level (high or low) of
apoptotic response hMDMs obtained from individual donors can
be divided into two general groups: susceptible and fairly resistant
(majority) to S. aureus-induced apoptosis. In all experiments
described below we routinely use the later group of hMDMs as
more representative. Furthermore, most interesting results were
verified using the RAW 264.7 cell line.
Infection of macrophages with S. aureus protects cells
from STS-induced cell death
To evaluate whether infection with S. aureus is able to inhibit cell
death, human (hMDMs) and mouse macrophages (RAW 264.7),
of both infected and control cells, were treated with staurosporine,
a potent inducer of apoptosis commonly used in a macrophage
model applied to study cytoprotective effect of various bacteria
[20,34]. As expected, staurosporine, at a concentration of 1 mM,
efficiently induced control hMDMs cell death, as revealed by
MTT and LDH cytotoxicity assays (Fig. 2A and 2B, respective-
ly). Conversely, S. aureus phagocytosis had no effect on the
reduction of tetrazolium (MTT) into its insoluble formazan
product, nor did it cause the release of LDH. Moreover, even at
the highest levels of infection there was no significant cleavage of
MTT. Notably, S. aureus-infected hMDMs were significantly
protected against the lethal effects of STS. Indeed, they retained
100% of their mitochondrial activity which was reduced to 60% in
mock-infected cells treated with STS (Fig. 2A). In addition, a
much higher percentage of infected cells treated with STS
maintained plasma membrane integrity than similarly treated
control macrophages, as indicated by lactate dehydrogenase
(LDH) activity in culture media samples (Fig. 2B). This
cytoprotective effect of hMDM STS-induced cell death was
observed all the way up to 96 h post-infection (data not shown).
The effect was maximal at 24 h and somehow less profound but
still significant at the later stages of infection (Fig. 2C).
S. aureus phagocytosis leads to infection of only a subset of
macrophages (50–70%) from a given population, and it can be
anticipated that cells free of bacteria would be predominantly
susceptible to STS. Therefore this effect would significantly mask
the protective effect exerted by infection (Fig. 2). To verify this
notion, and to determine the infection and cell vitality status of
individual macrophages, we performed fluorescence microscopy
analysis. Macrophages (RAW 264.7) were infected with FITC-
labeled S. aureus, and, after treatment with STS, counterstained
with propidium iodide. Notably, S. aureus-infected cells (green
positive staining, asterisk) had anadherent morphology, and an
intact cell membrane (PI negative staining), whereas the majority
of non-infected cells had leaky membranes (PI positive staining)
and a non-adherent morphology indicating cell death (Fig. 3,
merged; Table 2). Collectively our data strongly argues that
infection with S. aureus reduces the sensitivity of macrophages to
staurosporine-induced apoptosis.
S. aureus infection prevents STS and butyric acid-induced
activation of caspase-3 in macrophages
To further analyze mechanisms hindering the cell death of
macrophages infected with S. aureus, we determined whether
apoptosis inhibition takes place upstream or downstream of
caspase-3 activation. To this end we evaluated caspase activity in
human and mouse macrophages upon induction of apoptosis by
treatment with STS and butyric acid, as well as Fas ligation by
specific antibodies. As expected, in the non-infected control cells
(hMDMs and RAW 264.7) both STS and butyric acid induced a
very high level of caspase-3 activity in contrast to anti-Fas
antibodies, which exerted only a minor effect. Therefore, we used
STS for all subsequent experiments. Significantly lower levels were
induced in cultures infected with S. aureus, with 59.3%68.4 and
45.3%67.1 of control cell activity (treated with STS or butyric
acid, respectively) observed (Fig. 4A).
To further confirm that caspase-3 activation is hindered in S.
aureus-infected macrophages we performed Western Blot analysis
of cell extracts from cultures treated with STS to detect active
forms of caspase-3. In stark contrast to STS-exposed non-infected
hMDMs, which presented a strongly immunoreactive band
corresponding to active caspase-3 (p17), such a band was
completely absent in control and S. aureus infected cultures,
including those treated with STS (Fig. 4B).
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Taking into account that the inhibition of procaspase-3 activation
may have resulted from general phagocytosis-induced macrophage
activation, we investigated if the observed effect was specific for live
S. aureus uptake. Thus, we compared caspase-3 activity in PMA-
treated murine macrophages and macrophages which had
phagocytosed B. subtilis, E. coli live or heat-killed S. aureus, or latex
Figure 1. S. aureus infection of hMDMs causes transient caspase-3 activation in a donor-dependent manner without development of
late apoptotic features. hMDMs were allowed to phagocytose S. aureus at a ratio of 50 bacteria per macrophage (MOI 1:50) for 2 h. Bacteria were
then removed and cells were cultured for an additional 6–168 h. At the indicated time points the infected cells were analyzed for apoptotic changes.
(A) Phosphatidylserine (PS) externalization to the cell surface was examined under a fluorescence microscope after staining cells with FITC-annexin V.
Upper and lower panels show transmission and fluorescent light micrographs (620), respectively, of control, mock-infected macrophages (left panel)
and S. aureus-infected cells (right panel) maintained in culture for 6 h. The presented photographs are representative of a minimum of 20 fields
observed during 3 independent experiments. (B) The activity of caspase-3 (RFU/min) in infected and control cultures of hMDMs originating from 25
blood donors was measured with DEVD-AFC 24 h after S. aureus phagocytosis. (C) Infected macrophage cultures were maintained for 168 h post-
phagocytosis and caspase-3 activity (RFU/min) was determined at 24 h intervals. The figure is representative of several experiments, each performed
in triplicate, using hMDMs cultures responding to S. aureus infection with strong procaspase-3 activation. Macrophages treated with STS for 24 h
were used as a positive control. STS, staurosporine. (D) Lack of DNA fragmentation examined by agarose electrophoresis at 24, 48 and 72 h after S.
aureus phagocytosis (representative result). (E) Assessment of chromatin condensation in infected hMDMs (24 h post-phagocytosis) using DAPI
staining fluorescence microscopy (1006). Only occasional, slight chromatin condensation was visible (arrowheads). The results presented are from
one representative experiment out of 5. Scale bars = 10 mm.
doi:10.1371/journal.pone.0005210.g001
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beads (each of them at the same MOI = 1:5); with each sample
being subsequently treated with STS. Engulfment of these particles
(bacteria or beads) alone did not cause any significant procaspase-3
activation 24 h post-phagocytosis. The proapoptotic effect of STS,
measured as caspase-3 activation, was maximal in control, resting
cells; whilst in cultures engaged previously in phagocytosis, caspase-
3 activity was diminished (Fig. 5). In contrast to treatment with
PMA and the uptake of latex beads, E. coli or B. subtilis, which only
slightly affected procaspase-3 activation, the phagocytosis of S. aureus
caused a significant decrease in caspase-3 activity. Notably, the most
profound effect was exerted by the ingestion of live, rather than
dead, S. aureus cells. Indeed this was found to be at only 15.6%63.3
of those levels observed for control, resting cells treated with STS.
This is in clear contrast to the effects exerted after the engulfment of
dead bacteria, which only partially reduced caspase-3 activation
(55.4%611.6 of control value) in response to STS.
Taken together, these data suggest that intracellular infection
with S. aureus may inhibit a key step in the mitochondrial pathway
required for apoptosis. To our knowledge, such a profound
inhibition of cell death in S. aureus-infected macrophages is an as
yet undocumented event in the in vitro model system and prompted
us to elucidate the mechanism(s) of this phenomenon.
S. aureus suppresses STS-induced apoptosis in hMDMs by
preventing the release of cytochrome c from
mitochondria
The release of mitochondrial cytochrome c into the cytosol, and
the activation of caspase-3, have both been reported as playing an
essential role in cellular apoptosis [25]. To investigate whether the
STS-induced release of cytochrome c is blocked in S. aureus-
infected hMDMs, the amount of cytochrome c in cytosolic and
mitochondrial fractions was analyzed via semiquantitative Western
blot analysis. The purity of the mitochondrial and cytoplasmic
fractions was tested by western blotting with an antibodies directed
against cytochrome c oxidase subunit IV (COX IV), b-actin, and
cathepsin D as mitochondrial, cytoplasmic and lysosomal marker,
respectively. We found mitochondrial fraction basically free of
cytoplasmic and lysosomal contamination. By direct comparison
Figure 2. S. aureus-infected hMDMs show a decreased susceptibility to the cytotoxic effects of STS. Control and S. aureus-infected cells
(24 h post-phagocytosis) were treated with STS at a concentration of 1 mM for 24 h and cell viability was evaluated by MTT (A) and LDH (B) assays. (A)
The mitochondrial metabolic activity is presented as the percentage of control hMDMs, which were considered to be 100%. (B) Plasma membrane
permeabilization or cell lysis induced in mock- and S. aureus-infected hMDMs was determined as LDH activity levels. The experimental value was the
LDH activity in the conditioned medium from the control and infected cells after STS stimulation for 24 h. The data shown is representative of at least
three separate experiments, performed in triplicate, using hMDMs derived from different donors. **, p,0.01. (C) The cytotoxicity measured as the
LDH activity levels in the conditioned medium from the mock- and S. aureus-infected hMDMs (24 and 96 h p.i.) after treatment with STS for 24 h. The
data shown is representative of at least three separate experiments, performed in triplicate, using hMDMs derived from different donors. **, p,0.01.
doi:10.1371/journal.pone.0005210.g002
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of the intensity of a cytochrome c-specific band in mitochondria-
enriched and cytosolic fractions, we found that in control hMDMs
most of the cytochrome c was present in mitochondria-enriched
fractions (Fig. 6). The phagocytosis of S. aureus only slightly
affected the balance between mitochondrial and cytoplasmic
cytochrome c content (Fig. 6B). In stark contrast however, STS-
treatment of uninfected, resting macrophages caused release of
mitochondrial cytochrome c into the cytoplasm, with the majority
of cytochrome c found in the cytosolic fraction. Significantly, this
cytochrome c release was blocked to control levels if STS-treated
cells were infected with S. aureus (Fig. 6A, B). These data argue
that the presence of intracellular S. aureus within macrophages
attenuates the propapototic effect of STS by preventing STS-
induced release of cytochrome c from mitochondria.
Mitochondria play a central role in the control of the apoptotic
process. By opening permeability transition pores in the inner
mitochondrial membrane, membrane potential (YM) rapidly
dissipates. This process is considered to be a major determinant
of the cellular commitment to death [35]. To examine whether the
infection of hMDMs with S. aureus affects the loss of the
mitochondrial potential induced by STS, cells were loaded with
Mito-Tracker Red CMXRos at various time points after STS
stimulation and the DYM was analyzed by flow cytometry.
The infection of macrophages (derived from individual donors)
by S. aureus caused, in the majority of cases (62.5%), only a small,
statistically insignificant decrease in the mean fluorescence
intensity (MFI), a measure of YM, in comparison to control
mock-infected cells (Fig. 7). Nevertheless, in hMDMs cultures
derived from (37.5%) donors, S. aureus infection significantly
lowered YM 24 h post-phagocytosis. The drop of MFI correlated
well with the increased level of cytochrome c in the cytoplasm (data
not shown) and the activation of caspase-3 in these cultures
(Fig. 1B). Despite these variations, in all of the investigated
cultures, staphylococcal infection radically protected the STS-
induced decline of YM, as illustrated by representative examples
shown in Fig. 7B. Collectively, these data suggests that S. aureus
induces an antiapoptotic program by stabilizing YM, blocking
cytochrome c release and subsequent caspase-3 activation.
S. aureus infection induces the expression of
antiapoptotic regulators in hMDMs
It has previously been described that bacterial pathogens may
regulate cell death via the modulation of host cell gene expression,
in order to prolong their intracellular survival [36–38]. Therefore,
based on our observation that S. aureus induces cytoprotective
mechanisms within macrophages, we analysed the gene expression
profiles of human monocyte-derived macrophages 8, 24 and 48 h
after S. aureus phagocytosis. Analysis of the changes in gene
expression, evaluated in five independent microarray experiments
in hMDMs derived from separate individuals, indicated that
whereas the level of control transcripts, including 18S rRNA, was
unaffected, a significant increase in the expression of antiapoptotic
genes was observed (Table 3). Interestingly, the upregulation of
these antiapoptotic genes was accompanied by a simultaneous
Figure 3. The intracellular presence of S. aureus protects macrophages (RAW 264.7) from STS-induced cell death. Macrophages were
allowed to phagocytose FITC-labeled S. aureus at a ratio of 5 bacteria per macrophage (MOI = 1:5) for 2 h. Extracellular bacteria were removed and
cells were cultured in media with antibiotic for an additional 24 h, before being treated with STS (1 mM) in fresh culture medium for 3 h.
Subsequently, cell viability (PI staining), as well as the presence of intracellular bacteria, were analyzed using a fluorescence microscope. (The figure
presents transmission and fluorescent light micrographs of macrophage cultures infected with FITC-labeled S. aureus and treated with STS. The
merged panel represents PI stained dead uninfected cells (arrows); and viable macrophages with intracellular S. aureus which maintained their cell
membrane integrity (asterisks). The figure shows representative results of three independent experiments.
doi:10.1371/journal.pone.0005210.g003
Table 2. Cell counts of viability assay experiments.
Experiment No.
% of PI-negative (live
cells) containing
intracellular S. aureus







Mouse macrophages infected with FITC-labeled S. aureus were treated with STS
for 24 h, stained with PI and visualized by fluorescence microscopy. The table
shows representative results of three independent experiments.
doi:10.1371/journal.pone.0005210.t002
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downregulation in the expression status of some proapoptotic
determinants (Table 3).
Since S. aureus apparently blocks apoptosis in macrophages
upstream of the release of mitochondrial cytochrome c, we
investigated the possible mechanism of this inhibition. To this end,
we compared the expression levels of genes strictly involved in the
mitochondrial cell death pathway. Microarray results revealed that
from this group of genes, only MCL1 was significantly affected by
S. aureus phagocytosis. To verify changes in the MCL1 expression
in more specific terms, quantitative real time RT-PCR was carried
out to measure the level of gene expression at different time points
post-phagocytosis. As calculated based on the reference gene EF-2,
an internal control whose expression was stable under all
conditions tested, MCL1 expression increased approximately 4-
fold in cells 8 h after S. aureus phagocytosis (Fig. 8A). The elevated
expression of MCL1 decreased during the course of infection, yet
at 72 h it was still 2-fold higher than that in mock-infected control
cells (Fig. 8A). As a negative control, reverse transcriptase was
excluded from the cDNA synthesis reaction to control for possible
DNA contamination, and no amplification was observed (data not
shown).
The microarray analysis revealed no significant changes in the
expression levels of either BCL2 or BAX. Nevertheless, because
these genes are crucial in the regulation of mitochondrial
membrane permeability we examined their expression by
quantitative RT-PCR. This analysis revealed substantial upregula-
tion of BCL2, but a small and statistically insignificant increase in
BAX expression (Fig. 8B) in hMDMs 8 h after S. aureus
phagocytosis.
Taken together, the combined results of our microarray and
quantitative RT-PCR analyses provides strong evidence that the
infection of monocyte-derived macrophages with S. aureus
upregulates the transcription of antiapoptotic genes, which likely
explains the observed restricted release of cytochrome c from
mitochondria upon STS treatment.
Discussion
In a recent in vitro study by our group we have shown that S.
aureus phagocytosed by human monocyte-derived macrophages
(hMDMs) can survive intracellularly for 4–7 days without affecting
host cell viability. This proceeds until the cells are suddenly lysed
by escaping bacteria, which then go on to proliferate to high
numbers [13]. In the present study we have further investigated
this phenomenon and have shown that the viability of infected
cells is maintained despite the appearance of early apoptotic
features, including phosphatidylserine externalization, decreased
mitochondrial membrane potential, cytochrome c release and high
levels of caspase-3 activation. Notably, there was no finalization of
PCD, manifested by DNA fragmentation, or the development of
Figure 4. hMDMs infection with S. aureus inhibits caspase-3 activation induced by STS and butyric acid. (A) The effect of S. aureus
infection on caspase-3 activity was measured with DEVD-AFC as a substrate in hMDMs after 24 h stimulation with STS or BA. The diagram is a
representative result of an experiment performed in triplicate using macrophages isolated from a single donor. Bars represent mean6SD of caspase-3
activity (RFU/min). The caspase-3 activity of mock-infected cells was regarded as 100%. (B) Inhibition of procaspase-3 processing induced by STS in S.
aureus-infected hMDMs. Macrophages with or without S. aureus infection were STS treated, and 24 h post-infection cells were lysed for Western Blot
analysis using antibodies against caspase-3. Caspase-3 antibody staining was developed with a secondary antibody conjugated to horseradish
peroxidase followed by visualization using ECL as described in the Materials and Methods.
doi:10.1371/journal.pone.0005210.g004
Figure 5. Inhibition of caspase-3 activation induced by STS in
RAW 264.7 macrophages is dependent on S. aureus phagocy-
tosis. The effect of live (Sa l) and heat-killed (Sa d) S. aureus, B. subtilis
(Bs), E. coli (Ec) and latex beads (LTX) phagocytosis (MOI = 1:5) on STS-
induced caspase-3 activity in RAW 264.7. After phagocytosis cells were
cultured for 24 h and treated with STS for 3 h. Caspase-3 activity was
measured from cell lysates using DEVD-AFC as a substrate. STS-induced
activity in control, resting cells was taken as 100%. Data are the
mean6SD values from three independent experiments, each per-
formed at least twice. *p,0.05; ***, p,0.001 significance as indicated in
the figure.
doi:10.1371/journal.pone.0005210.g005
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Figure 6. The infection of hMDMs with S. aureus prevents STS-stimulated cytochrome c release into the cytoplasm. Infected and
control hMDMs were incubated with STS for 3 h and mitochondrial and cytosolic fractions were prepared as described in the Materials and Methods.
(A) A representative immunoblot selected from four separate experiments. Cytochrome c was visualized by Western Blotting using anti-cytochrome c
specific antibodies. Purity of fractions was ,70% as assessed by anti-b-actin and anti-COX IV antibody (data not shown). (B) Individual band intensity
acquired by blot scanning and expressed in arbitrary units.
doi:10.1371/journal.pone.0005210.g006
Figure 7. S. aureus phagocytosis partially protects infected hMDMs from an STS-induced drop in mitochondrial membrane
potential. (A) Control and S. aureus-infected cells were stimulated with STS for 3 hours. Subsequently the cells were stained with CMXRos and
subjected to flow cytometry analysis as described in the Materials and Methods. Representative histograms are shown. (B) The number of cells with
depolarized mitochondrial membranes was determined. The diagram illustrates a result of several performed experiments using hMDMs derived from
different donors. Bars represent the mean amount of depolarized cells calculated as % of the total analyzed cells 6SD; *, p,0.05; NS, not significant.
doi:10.1371/journal.pone.0005210.g007
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features of secondary necrosis. In this regard S. aureus clearly
resembles Legionella pneumophila, an obligatory intracellular parasite
of macrophages. The major difference between these two
organisms is that L. pneumophila proliferates inside macrophages
before lysing the host cells [21].
Induction of the apoptotic program by phagocytosed S. aureus
appeared to be somewhat donor-dependent. Of the 25 individual
donor-derived cultures of hMDMs, 12 cultures infected with S.
aureus led to variable degrees of transient PCD activation. In all 12
cases the level of early apoptotic markers, including caspase-3
activity, peaked at 24 h post-phagocytosis and then returned to
baseline levels. This indicates that cells from different individuals
can respond differently to infection with S. aureus. It is likely that in
nonresponsive cultures antiapoptotic mechanisms prevail from the
outset of infection, while in responsive cells a balance between pro-
and apoptotic pathways is established, protecting the infected
macrophages from death. It would of great interest to determine if
this difference translates into an altered, individual susceptibility to
S. aureus infection.
The resistance of adherent macrophages to apoptosis is striking,
particularly in context of the high susceptibility of circulating
phagocytes (neutrophils and monocytes) to S. aureus-induced cell
death [39]. In these cells the phagocytosis of S. aureus preferentially
mediates cell death by the mitochondrial (intrinsic) apoptotic
pathway, manifested by a rapid disruption of mitochondrial
homeostasis, cytochrome c release, sequential activation of
caspase-9 and -3 and consequential nuclear DNA fragmentation
[17]. This suggests that the intrinsic signalling pathway of
apoptosis is affected in the infected macrophages. Indeed, this
was confirmed by showing that S. aureus-infected macrophages
were protected from staurosporine-induced apoptosis, but not
from cell death induced by activation of the extrinsic pathway via
FAS receptor ligation on the cell surface.
The proapoptotic activity of staurosporine targets the mito-
chondria, causing release of cytochrome c and subsequent caspase-
3 activation [40]. In infected macrophage cultures, staurosporine-
induced release of cytochrome c, and the associated caspase
activation, was significantly suppressed in comparison to mock-
Table 3. Selected genes involved in apoptotic cell death with altered expression observed in hMDMs 8, 24 and 48 h after S. aureus
phagocytosis.
Entrez Gene Anti-apoptosis 8 h 24 h 48 h Ref.
TNFAIP3* 2.0 3.0/3.1 3.0/3.0 [53]
CD40* 4.4/2.9/3.3 5.5/3.2/3.6 2.6 [54]
CFLAR* 2.2/3.1/3.7/3.4/2.5 2.2/2.6/3.7/3.9/2.3 2.0/2.1/2.3/2.5 [55]
NLRP3* 2.1/2.1 [56]
GIMAP5* 2.6/2.4 2.2 [57]
NFkB1 2.2 [58]
NFkB2* 2.3/2.0 2.1/2.1 [58]
VEGFA* 4.7/10.9/3.7 4.9/9.3/4.1/5.7 2.8/5.2 [59]
MCL1* 2.1/3.4 2.2/2.5/4.1 2.0 [60]
BCL3 2.0 [61]
STAT3* 2.3/2.1/2.5 2.1 [62]
STAT4 6.0 6.3 3.5 [62]
BIRC3 3.3 3.5 3.1 [63]
TRAF1* 2.9/3.2 3.2/3.8 2.6/2.7 [64]
Pro-apoptosis 8 h 24 h 48 h Ref.
RHOBTB2 22.7 22.3 [65]
TNFRSF21 22.3/22.6 [66]
CASP1 3.0 5.6/3.3/3.9 [67]
CASP4 2.3 3.0 [68]
TNFRSF 10A 2.3 [66]
TNFSF 10 37.2/31.1/33.3 [66]
TRADD 3.3/2.5 [69]
Anti-/Pro-apoptosis 8 h 24 h 48 h Ref.
TNF 11 21.6 [70]
STAT1 3.3 5.5/2.6 2.4 [62]
STAT2 3.8/5.1 2.6/3.1 [62]
CASP1 3.0 5.6/3.3/3.9 [67,70]
CASP10 2.9 [71,72]
Data given are the mean fold-change from five independent samples using Affymetrix microarrays that compare transcript levels in uninfected and S. aureus-infected
hMDMs.
*, genes represented by more then one probeset on the microarray.
doi:10.1371/journal.pone.0005210.t003
S. aureus Cytoprotective Effect
PLoS ONE | www.plosone.org 11 April 2009 | Volume 4 | Issue 4 | e5210
infected cells. This effect was observed regardless of the initial
response of macrophages to S. aureus infection. Notably, protection
was limited to a subset of cells which contain intracellular bacteria,
whilst non-infected macrophages succumbed to apoptotic cell
death. This means that the protective effect of S. aureus on STS-
induced cell death, determined using whole cultures would be
much higher if the assay was restricted only to those infected
macrophages.
The observed cytoprotection was apparently S. aureus-specific,
since engulfment of B. subtilis, E. coli, latex beads or prestimulation
with phorbol ester (PMA) yielded practically no effect. These
results exclude signaling pathways induced by the phagocytosis of
inert particles (latex beads), PMA-activated kinases, and receptors
engaged in the recognition and uptake of B. subtilis and E. coli, as
being essential for protecting macrophages from STS-induced
death. In the case of the partial protection yielded by phagocytosis
of heat-killed S. aureus we hypothesize that this is due to the
activation of macrophages by staphylococcal products (e.g.,
lipoteichoic acid or peptidoglycan), sensed by intracellular pattern
recognition receptors (NODs) [41]. Moreover, lipoteichoic acids
are known to delay the spontaneous apoptosis of neutrophils and
increase their life-span in vivo [42]. Interestingly, the level of NOD2
transcript dramatically increased 24 h after S. aureus phagocytosis
(data not shown) suggesting that NOD2 may contribute to sensing
of the intracellular presence of S. aureus and contribute to the
cytoprotective effect elucidated by phagocytosis of killed S. aureus.
The most compelling observation, however, is the maximum level
of protection yielded by the engulfment of live bacteria, which was
significantly higher than that elicited by killed S. aureus. This
indicates that the induced cytoprotection is the result of cross-talk
between live, metabolitically active intracellular S. aureus and their
macrophage host. In obligatory intracellular pathogens, including
Chlamydia sp. and Legionella pneumophila, CPAF and SidF proteins,
respectively, have been found as directly interfering with the
execution of apoptosis. While CPAF exerts its cytoprotective effect
by specifically stimulating the targeted degradation of the BH3
proapoptotic proteins, SidF neutralize Bcl-2 proteins with
proapoptotic activities [43,44]. Such factor(s), should they exist,
have yet to be identified in S. aureus.
Our findings clearly indicate that S. aureus protects infected
macrophages against STS-induced apoptotic cell death by
preserving mitochondrial membrane potential and blocking
cytochrome c release into the cytoplasm. The integrity of
mitochondrial membranes is controlled by members of the Bcl-
2/Bax protein family, with the balance between pro- and
antiapoptotic members of these families playing an important role
in determining the life-or-death decision of the cell [25].
Consistent with this dogma we find that S. aureus does not alter
significantly the expression of Bax, a key proapoptotic member of
the Bcl-2 family, in infected macrophages, but instead strongly
upregulates the expression of BCL2 and MCL1 genes, which
stabilize mitochondrial membrane potential.
Bcl-2 protects cells from a wide range of cytotoxic insults,
including cytokine deprivation, UV and gamma irradiation, and
chemotherapeutic drugs. This protein is largely membrane
associated, and like its antiapoptotic homologues, can bind active
BH3-only proteins, and as a result of this interaction likely prevent
the release of cytochrome c from mitochondria [26,27]. On the other
hand, myeloid cell leukemia-1 protein (Mcl-1) can interact directly
with the pro-apoptotic factors Bax and Bak, inhibiting their ability to
initiate cell death [45]. This latter antiapoptotic pathway is exploited
by M. tuberculosis, which induces resistance in infected macrophages
by up-regulation of MCL1 expression [46]. MCL1 is an early-
response gene, expressed during critical transitions in cell phenotype
that can be rapidly induced and repressed [47] in contribution of
many cell signalling pathways like JNK/STAT3, PIK3/AKT or
NFkB [48]. As such, our data demonstrates that the kinetics of
MCL1 expression correlate with S. aureus survival. At the beginning
of infection bacteria are eliminated very effectively (from 108 to 107
in first 24 h p.i.) [13]; apparently resulting from the initially effective
mobilization of antimicrobial potential. At this time the highest level
of MCL1 expression was observed from the entire course of infection.
In following days the amount of the MCL1 transcript decreases in
parallel with the diminishing numbers of viable intracellular S. aureus.
Despite this decreased expression of MCL1, cytoprotection was
sustained up to 4 days post S. aureus infection.
A recent study has shown that Mcl-1 is dispensable for
macrophage survival in vivo [49]. Therefore, the involvement of
Figure 8. Staphylococcal infection of hMDMs results in changes in expression of apoptosis-related genes. (A) Upregulation of the
antiapoptotic MCL1 gene in hMDMs. The expression level of MCL1 in uninfected and S. aureus-infected macrophages was monitored by quantitative
real-time RT-PCR as described in the Materials and Methods. Data given are the mean values calculated from the results of three independent real
time reactions. (B) Relative changes in mRNA expression of BCL2 and BAX 8 h after S. aureus phagocytosis by macrophages. The data shown is
representative of three separate experiments, performed in triplicate, using hMDMs derived from different donors. Bars represent mean relative
expression 6SD; *, p,0.05; **, p,0.01; NS, not significant.
doi:10.1371/journal.pone.0005210.g008
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alternative cytoprotective mechanism activated in S. aureus-infected
macrophages is highly probable. In keeping with this, our
microarray analysis of gene expression revealed that S. aureus
infection caused up-regulation of 14 antiapoptotic genes, and
down-regulation of transcripts encoding 2 proapoptotic determi-
nants. Notably, the expression of several proapoptotic genes was
also upregulated. However, the increased expression of these genes
was observed predominantly at 8 h, whereas the upregulation of
antiapoptotic genes was sustained for up to 48 h. Finally, the level
of transcripts of few genes with mixed pro- and antiapoptotic
functions were elevated in infected macrophages, but their effect
on cell survival in our experimental model was not determined.
Therefore, we proposed a model whereby S. aureus alters the
profile of host gene expression in infected macrophages, leading to
an inhibition of apoptosis. In this model signaling via pattern
recognition receptors, which activate the NFkB transcriptional
factor, may explain the partial cytoprotection induced by heat-
killed S. aureus. These conclusions are strongly supported by the
notion that several intracellular pathogens induce a resistance to
apoptosis within infected cells through robust alterations in gene
expression patterns [41,42,50,51]. This is most certainly the case
for C. pneumoniae, which mediated this process via activation of
NFkB [52]. In our study we also observed activation of NFkB
shortly after S. aureus phagocytosis (data not shown). However, it
needs to be investigated weather changes in other genes expression
were dependent on the NFkB activity.
Taken together, the modulation of apoptosis in human macro-
phages by S. aureus seems to be a novel occurrence. During the early
stages of infection S. aureus induces strong caspase-3 activation, whilst
also triggering robust antiapoptotic mechanism(s). This latter event is
associated with the down-regulation of proapoptotic genes and
significant up-regulation of antiapoptotic genes, especially those
preserving the potential of mitochondrial membrane and blocking
cytochrome c release. Rigorous antiapoptotic signaling cascades
apparently counteract the effect of caspase-3 activation, and
efficiently prevent activation of the intrinsic, mitochondria-dependent
pathway of cell death, rendering them refractory to potent stimulators
of the intrinsic apoptotic pathway. As S. aureus induces apoptosis in
human monocytes and neutrophils [17,39], as well other eukaryotic
cells [8,9], it seems that activation of the antiapoptotic machinery is
macrophage-specific. Although the precise mechanisms of antiapop-
totic control mediated by S. aureus (from the standpoint of the bacterial
factors involved) remain to be elucidated, our findings seem to have
significant implications for staphylococcal pathogenicity. The
inhibition of apoptosis in macrophages infected with the S. aureus
Newman strain resistant to intracellular killing [13] prolongs the
integrity of these mobile cells, and may significantly contribute to
pathogen dissemination and the chronic character of some
staphylococcal infections. Conversely, the resilience of infected
macrophages to pathogen-induced damage may be essential for
regulating inflammation and immune responses to S. aureus. Thus it is
clear that a deeper understanding of how S. aureus modulates the
functions of macrophages will be of prime importance to the
development of novel therapeutic interventions, and other mecha-
nisms by which to control diseases caused by this bacterium.
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